Precursor Lymphoid Neoplasm — Trials

Precursor Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,154 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 567
Recruiting: 344
Ph III recruiting: 27
Growth YoY: −11.9%
Industry share: 13%
Top sponsor: City of Hope Medical Center
Termination share: 33.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (286)

clinicaltrialsPublishedShowing 1–50 of 91 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06427330	Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia	unknown	Phase 2	21	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Jul 30, 2024	clinicaltrials
NCT06503094	CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors	unknown	Phase 1 / Phase 2	80	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER